Lam Research Q2 Earnings Beat: Can Strong Guidance Lift the Stock?

30.01.25 16:37 Uhr

Werte in diesem Artikel
Aktien

720,00 EUR -3,90 EUR -0,54%

95,00 EUR 2,00 EUR 2,15%

Indizes

21.508,1 PKT 96,7 PKT 0,45%

19.681,8 PKT 49,4 PKT 0,25%

1.854,4 PKT -8,4 PKT -0,45%

6.071,2 PKT 31,9 PKT 0,53%

Lam Research LRCX reported second-quarter fiscal 2025 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.LRCX reported second-quarter fiscal 2025 non-GAAP earnings of 91 cents per share, which beat the Zacks Consensus Estimate by 4.6%. The bottom line increased 7% on a year-over-year basis, primarily driven by higher revenues due to robust demand in DRAM and Foundry Logic and disciplined cost and operational management.In the second quarter of fiscal 2025, LRCX reported revenues of $4.38 billion, which surpassed the consensus mark by 1.6%. The top line increased 5% from the year-ago quarter’s $4.17 billion.Buoyed by better-than-expected second-quarter performance, Lam Research has released a strong outlook for the third quarter of fiscal 2025. LRCX stock has underperformed the Zacks Electronics - Semiconductors industry. In the past year, LRCX shares have lost 8.9% against the industry’s return of 42.9%. We expect that the company’s overwhelming quarterly performance, along with its upbeat outlook, will help LRCX stock to recover.Lam Research Corporation Price, Consensus and EPS Surprise Lam Research Corporation price-consensus-eps-surprise-chart | Lam Research Corporation QuoteLRCX’s Segment in DetailsLam Research’s System revenues were $2.63 billion (60% of the total revenues), up 9.7% from the previous quarter. System revenues grew 14.2% year over year. The reported figure missed the Zacks Consensus Estimate of $2.69 billion.In the Customer Support Business Group, revenues for the reported quarter were $1.75 billion (40% of the total revenues), down 1.4% from the previous quarter and up 20% year over year. The figure beat the consensus mark of $1.61 billion.LRCX’s Regions in DetailChina, Korea and Taiwan accounted for 31%, 25% and 17% of Lam Research’s total revenues, respectively, for the fiscal second quarter. Japan, Southeast Asia, the United States and Europe accounted for 8%, 7%, 9% and 3% of total revenues, respectively.Operating Details of LRCXThe non-GAAP gross margin was 47.5%, which contracted 70 basis points (bps) from the previous quarter.Non-GAAP operating expenses were $735 million, up 1.8% from the previous quarter. The non-GAAP operating margin was 30.7%, contracting 20 bps from the previous quarter’s 30.9%.LRCX’s Balance Sheet & Cash FlowAs of Dec. 29, 2024, cash and cash equivalents were $5.67 billion compared with $6.08 billion as of Sept. 29, 2024.Cash flow from operating activities was $742 million for the reported quarter, down from $1.57 billion in the previous quarter.In the reported quarter, Lam Research paid out dividends of $297.6 million and repurchased shares worth $650 million.LRCX Provides Strong GuidanceFor third-quarter fiscal 2025, LRCX expects its revenues to be $4.65 billion (+/- $300 million). The Zacks Consensus Estimate for the same is pegged at $4.32 billion.The non-GAAP gross margin is projected at 48% (+/-1%), whereas the non-GAAP operating margin is expected to be 32% (+/-1%).Non-GAAP earnings per share are projected to be $1 (+/- 10 cents) on a diluted share count of 1.3 billion. The Zacks Consensus Estimate for the same is pinned at 87 cents per share.Zacks Rank & Stocks to ConsiderCurrently, LRCX carries a Zacks Rank #4 (Sell).Bill Holdings BILL, Marvell Technology MRVL and Gitlab GTLB are some better-ranked stocks that investors can consider in the broader Zacks Computer & Technology sector.Bill Holdings, Marvell Technology and Gitlab sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.The consensus mark for BILL’s 2025 earnings has been revised upward by 4 cents to $1.81 per share over the past 60 days, indicating a 13% year-over-year increase. BILL shares have gained 24.1% in the past year.The consensus mark for MRVL’s 2025 earnings has been revised downward by 10 cents to $1.56 per share over the past 60 days, indicating a 3.31% year-over-year increase. MRVL shares have risen 52.3% in the past year.The consensus mark for GTLB’s 2025 earnings has been revised upward by 17 cents to 63 cents per share over the past 60 days, indicating a 215% year-over-year increase. GTLB shares have lost 2.2% in the past year.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis Report Marvell Technology, Inc. (MRVL): Free Stock Analysis Report BILL Holdings, Inc. (BILL): Free Stock Analysis Report GitLab Inc. (GTLB): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Lam Research

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Lam Research Corp.

Wer­bung

Analysen zu Lam Research Corp.

DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
29.10.2018Lam Research NeutralB. Riley FBR
DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
17.10.2018Lam Research OutperformCowen and Company, LLC
DatumRatingAnalyst
29.10.2018Lam Research NeutralB. Riley FBR
01.10.2018Lam Research HoldDeutsche Bank AG
01.10.2018Lam Research NeutralMizuho
12.10.2016Lam Research Sector WeightPacific Crest Securities Inc.
21.04.2015Lam Research Sector PerformRBC Capital Markets
DatumRatingAnalyst
22.10.2015Lam Research UnderperformRBC Capital Markets
05.10.2015Lam Research UnderperformRBC Capital Markets
11.11.2010Lam Research sellCitigroup Corp.
29.07.2010Lam Research sellCitigroup Corp.
19.03.2009Lam Research underperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"